Pain interruption as therapy. Ketamine is an NMDA receptor antagonist that fundamentally interrupts the neurobiological mechanisms driving chronic pain. At sub-anesthetic doses, ketamine blocks NMDA receptors in the spinal cord and brain, preventing wind-up (the progressive amplification of pain signals) and resetting central sensitization-the state where the nervous system becomes hypersensitive to pain stimuli. Unlike medications that mask pain or procedures that address only structural damage, ketamine therapy directly interrupts the pathological pain processing that perpetuates chronic suffering. At Bluetail Medical Group, we recognize that pain itself must be interrupted to enable healing. Ketamine restores the nervous system's capacity to reset and recover.

Central Sensitization: Why Chronic Pain Persists

Acute pain serves a purpose-it alerts us to tissue damage and prompts protective action. In spinal conditions, however, pain often persists long after initial injury has healed. This persistent pain is not simply the sensation of structural damage; it reflects a change in how the nervous system processes pain signals-a phenomenon called central sensitization.

Central sensitization develops through a process called wind-up. When pain signals from damaged tissue repeatedly fire at spinal cord neurons, something pathological occurs: the neurons become increasingly sensitive. The same stimulus that initially produced a modest signal eventually produces an amplified response. This progressive amplification creates a vicious cycle where chronic pain becomes self-sustaining, independent of ongoing tissue damage.

This amplification is driven by NMDA (N-methyl-D-aspartate) receptors on spinal cord neurons. When pain signals activate these receptors repeatedly, calcium floods the cells, triggering cascades that upregulate pain-processing genes and increase neuronal excitability. The nervous system becomes hypersensitive. Light touch becomes painful. Normal movement triggers pain. The pain system itself has become the pathology.

Central sensitization explains pain that outlasts structural recovery. A disc herniation may resolve, but pain persists. An annular tear may heal, but neuropathic burning continues. These patients suffer not because their spine is still severely damaged, but because their nervous system remains in a state of amplified pain processing. Traditional treatments (physical therapy, injections, even surgery) often fail because they do not address the fundamental neurobiological dysregulation driving the pain.

How Ketamine Interrupts the Pain Cycle

Ketamine is an NMDA receptor antagonist. At sub-anesthetic doses (0.1-0.5 mg/kg infused intravenously over 45-90 minutes), ketamine blocks NMDA receptors before they can propagate the cascades that perpetuate wind-up and central sensitization.

By interrupting NMDA signaling, ketamine accomplishes what conventional pain treatments cannot:

  • Halts wind-up. The progressive amplification of pain signals is interrupted. The spinal cord neurons reset to lower baseline excitability.
  • Reduces central sensitization. Hypersensitivity to touch, movement, and normal stimuli diminishes as the nervous system's amplified gain is turned down.
  • Promotes neuroplasticity. By interrupting the pathological pain state, ketamine allows the nervous system to form new, healthier pain-processing patterns. This is not temporary suppression; it is neurobiological reset.
  • Modulates inflammation. NMDA receptor antagonism also reduces neuroinflammation-the chronic inflammatory state in the central nervous system that amplifies pain perception.

Critically, the benefits of ketamine extend beyond the infusion itself. In the weeks following treatment, many patients report sustained improvement in pain levels and function. This durability reflects a genuine change in nervous system processing, not temporary medication effect.

Pain Interruption as Therapy

At Bluetail Medical Group, our philosophy is that pain itself must be interrupted to enable healing. This principle guides our approach to regenerative medicine. When a patient is in chronic pain, their nervous system is in a state of heightened alarm. This alarm state impairs the very processes we are trying to harness for healing-tissue repair, neuroplasticity, functional recovery.

Ketamine therapy creates a neurobiological reset. By interrupting central sensitization and wind-up, ketamine restores the nervous system to a state where it can respond to regenerative treatments, participate in rehabilitation, and recover normal function. Patients who have failed conventional therapies often find that ketamine opens a door: pain is reduced enough that they can engage in physical therapy, that regenerative injections can be effectively integrated, that sleep and mood improve, that hope returns.

Ketamine is not the only tool we use. It is one component of our comprehensive regenerative approach. Combined with tissue-directed regenerative therapy (PRP, prolotherapy, cellular therapy), pain interruption allows these regenerative treatments to work optimally. The nervous system, no longer in constant alarm, can participate in healing.

The Procedure: What to Expect

Ketamine infusion therapy takes place in our clinical setting with full medical monitoring. The procedure is straightforward and well-tolerated.

A peripheral IV line is placed in your arm. We begin with a 5-10 minute saline flush to establish access. The ketamine is then infused slowly over 40-90 minutes, depending on your weight and tolerance. The infusion rate is carefully controlled to minimize dissociative effects while maximizing therapeutic benefit.

During the infusion, you may experience dissociative effects: a sense of floating, detachment, or mild visual changes. These effects are expected and completely resolve within 1-2 hours of completing the infusion. Some patients find these effects mildly unpleasant; others find them almost meditative. Regardless, they are not harmful and are not remembered as particularly distressing.

Throughout the infusion, your blood pressure, heart rate, and oxygen saturation are monitored continuously. A healthcare provider remains present at all times. After the infusion is complete, you rest in a recovery area for 30-45 minutes until the dissociative effects fully resolve and you feel comfortable. You will need a driver to take you home; you should not drive for the remainder of the day.

A typical course of treatment is 6-8 infusions over 2-4 weeks (usually twice weekly). Some patients require additional infusions; others achieve sustained benefit with fewer. The timing and frequency are individualized based on your response and clinical presentation.

Which Patients Benefit Most

Ketamine therapy is most effective for pain conditions driven by central sensitization and wind-up. These include:

  • Chronic neuropathic pain. Burning, shooting, or nerve-like pain in the spine or extremities-particularly when the pain outlasts the initial structural injury.
  • Treatment-resistant pain. Pain that has not adequately responded to conventional treatments (medications, injections, surgery, physical therapy).
  • Widespread pain with central sensitization. Patients whose pain has become amplified and now affects multiple body regions, reflecting dysfunction in central pain processing.
  • Pain with associated mood or sleep disturbance. Chronic pain and depression/anxiety often share NMDA dysregulation; ketamine addresses both pathways.
  • Patients preparing for or recovering from regenerative therapy. Ketamine pain interruption optimizes outcomes when combined with PRP, prolotherapy, or cellular therapy.

Ketamine is not a first-line treatment for acute pain or structural pathology that will respond to simpler interventions. It is a specialized tool for chronic pain conditions where conventional approaches have failed and where central sensitization is a primary driver of suffering.

If you have chronic pain that persists despite conventional treatments, we encourage you to discuss ketamine infusion therapy with Dr. Crane. A thorough evaluation will determine whether you are an appropriate candidate and how ketamine might fit into your comprehensive treatment plan.

Frequently Asked Questions

Ketamine blocks NMDA receptors in the spinal cord and brain. This prevents wind-up (the progressive amplification of pain signals from repeated stimulation) and resets central sensitization-the state where the nervous system becomes hypersensitive to normal stimuli. By interrupting these pathological pain processing mechanisms, ketamine allows the nervous system to recalibrate and recover its normal sensitivity thresholds. This is fundamentally different from opioids or anti-inflammatories, which do not address the underlying neurobiological dysregulation.
At the sub-anesthetic doses used in our protocols, ketamine is well-tolerated. Treatments are administered in a monitored setting with medical staff present throughout the infusion. Mild dissociative effects (a sense of detachment or floating) are expected during infusion and resolve completely within hours. Blood pressure and heart rate are monitored continuously. The primary contraindications are uncontrolled hypertension, active substance use disorder, and certain psychiatric conditions. We screen patients thoroughly before treatment to ensure safety. Ketamine has been used in clinical settings for over 60 years and has an excellent safety profile when administered by trained providers.
Ketamine administered in controlled clinical settings at sub-anesthetic doses for chronic pain does not produce addiction in patients without a personal history of substance use disorder. Addiction involves compulsive seeking and loss of control; ketamine infusion therapy is a structured medical treatment with a defined course (typically 6-8 infusions over 2-4 weeks). The effects of ketamine on pain are sustained even after infusions are completed, suggesting neurobiological reset rather than dependence. Patients with active substance use disorder are not candidates for this therapy.

Ready to Explore Your Options?

Schedule a consultation to discuss whether regenerative medicine is right for your condition.